Sarepta Therapeutics SRPT reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Sarepta Therapeutics reported in-line EPS of $-1.18 versus an estimate of $-1.18.
Revenue was up $69.40 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.71 which was followed by a 1.46% drop in the share price the next day.
Here's a look at Sarepta Therapeutics's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -1.27 | -1.13 | -1.89 | -1.29 |
EPS Actual | -0.56 | -0.77 | -0.19 | -1.52 |
Revenue Estimate | 206.44M | 198.61M | 173.42M | 162.64M |
Revenue Actual | 210.83M | 201.46M | 189.41M | 164.09M |
To track all earnings releases for Sarepta Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.